She is currently Co-Director of the Oncology
Service, Wills Eye Hospital, and Professor of Ophthalmology at Thomas Jefferson
University in Philadelphia. She has authored or coauthored 9 textbooks, over
1000 articles in major journals, nearly 300 textbook chapters, given nearly 600
lectureships, and has received numerous professional awards.
|The prestigious College eponymous lectures
will be presented by Professor David Williams
(USA) who will deliver the Edridge Green Lecture, and
Professor Phil Murray (Birmingham,
UK), delivering the Duke Elder Lecture.
The fifth Optic UK Lecture
will be delivered by Dr Gerrit Melles
(Netherlands), celebrating the collaboration between the College and
The scientific programme spans sub-specialities, and will be
contributed to by renowned international speakers from different locations in
support of our talented UK faculty.
We look forward to welcoming an
excellent faculty of international speakers at our 2013 Congress
He participated as a member of the
Executive Committee and Editorial Committee of the CRYO-ROP Study, as PI of the
Philadelphia Center in both CRYO-ROP and the ETROP trial, as a member of the
Executive Committee of the Vision in Preschoolers study.
Dimitri Azar is Dean of the College of Medicine at the University
of Illinois at Chicago. He holds the B.A. Field Chair in ophthalmologic
research, and is Distinguished Professor of Ophthalmology, Bioengineering and
|Dr. Azar joined the
University of Illinois at Chicago, in 2006, as Head of the Department of
Ophthalmology and Visual Sciences after serving as tenured Professor of
Ophthalmology at Harvard Medical School, Director of the Cornea Service at the
Massachusetts Eye and Ear Infirmary, Senior Scientist at the Schepens Eye
Institute, and as faculty at the Johns Hopkins School of Medicine.
Azar has been named one of The Best Doctors in America® and/or one of the
Castle Connolly regional Top Doctors in America annually since 1994. He is a
leader in basic science and clinically related vision research, making
significant contributions to the treatment of corneal diseases and to advances
in refractive surgery through mathematical analyses and applications of
advanced optics. His basic science research on matrix metalloproteinases in
corneal wound healing and angiogenesis has been continually funded by the
National Eye Institute R01 award since 1993.
Graham Quinn is a Professor of Ophthalmology at the University of
Pennsylvania and an Attending Surgeon and the Director of research for the
Division of Pediatric Ophthalmology at The Childrens Hospital of Philadelphia.
currently Study Chair and PI of the NEI-funded Telemedicine approaches to
evaluating acute-phase ROP study that is designed to evaluate validity,
reliability, feasibility, safety, and cost-effectiveness of a telemedicine
system to detect eyes of at-risk babies in need of a diagnostic exam by an
ophthalmologist experienced in ROP. He has been actively involved with
international ROP work for many years and served as a member of the committees
that produced the International Classification of ROP.
For more than 30 years, he has been
active in the care of patients with ocular tumours and in clinical research
related to tumours of the eyelids, conjunctiva, intraocular structures, and
orbit. He has given 1500 national and international lectures, including 69
||Dr Jerry Shields
Shields is director of the Oncology Service at Wills Eye Institute and
Professor of Ophthalmology Thomas Jefferson University. He was a resident at
Wills Eye Hospital and completed fellowships in ophthalmic pathology and
He has also received 28 national and international
academic awards for his contributions. Dr. Shields is married to Dr. Carol
Shields also practices on the Oncology Service of Wills Eye Institute and has
made many similar contributions. They have 7 children ranging from ages 24 to
12 years of age.
||Dr Carol Shields
Shields completed her residency in ophthalmology at Wills Eye Hospital in
Philadelphia in 1987 and subsequently did fellowship training in ocular
oncology, oculoplastic surgery, and ophthalmic pathology.
Shields is a member of numerous ocular oncology, pathology, and retina
societies and has delivered 30 named lectures in America and abroad. She has
been highly active in the American Academy of Ophthalmology. She practices
ocular oncology on a full time basis with her husband, Dr. Jerry Shields and
associates on the Oncology Service at Wills Eye Hospital. Each year the
Oncology Service manages approximately 500 patients with uveal melanoma, 120
patients with retinoblastoma, and numerous other intraocular, orbital, and
adnexal tumors from the United States and abroad.
He also gained Fellowship of the Royal
Australian and New Zealand College of Ophthalmology in 1999 and a Doctorate of
Medicine in 2005. In 2000, he undertook a Glaucoma Fellowship at Birmingham and
Midlands Eye Centre, Birmingham and in 2001 a Cataract, Cornea and Refractive
Fellowship at Moorfields Eye Hospital in London. Particular specialties include
lamellar corneal grafting and advanced management of complex glaucoma. Awards
include the Alcon/RACO Travelling Scholarship 2001, AUSCRS Film Festival 2001
and 2005 and the Pharmacia & Upjohn RACO Award 1998.
||Professor Graham Lee
Professor Graham Lee is from Brisbane, Australia. He originally completed his
Bachelor of Medicine and Surgery in 1991 and this was followed by a Master of
Medical Science in Ophthalmology in 1994.
He has an
active interest in Ophthalmic teaching having presented more than 200 lectures
at local, national and international levels as well as more than 70
publications in peer-reviewed journals and book chapters. He has lectured and
demonstrated surgery in developing countries such as Cambodia and Nepal and is
a chief examiner for the Cambodian Diploma in Ophthalmology program. His
current appointment includes Director of Cornea and Glaucoma Services, Chairman
of Qualifications and Education in the state of Queensland and holds the
academic title of Associate Professor of Ophthalmology at the University of